Richard J. Daly currently serves as the CEO of Catalyst Pharmaceuticals, Inc., a role he will officially start on January 1, 2024. He's had a busy career, previously holding executive positions like President at CARsgen Therapeutics and COO at Beyond...

Richard J. Daly currently serves as the CEO of Catalyst Pharmaceuticals, Inc., a role he will officially start on January 1, 2024. He's had a busy career, previously holding executive positions like President at CARsgen Therapeutics and COO at Beyond Springs Inc. Before that, he was the CEO of Neuralstem, Inc. and part of Broadridge Financial Solutions as CEO and President after it spun off from ADP. His leadership style is heavily focused on performance metrics and aligning executive pay with company success. In 2019, he earned over $10 million, showing the connection between his performance and compensation, which is structure to reward achievement. He has a strong background in finance and management, known for running the U.S. diabetes subsidiary of AstraZeneca where he managed $1.2 billion in revenue. Daly is also no stranger to the stock market; his holdings fluctuated significantly, peaking around $36 million in 2023. His insights into the pharmaceutical and fintech sectors make him a key player in these industries.